Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension.
BACKGROUND: Pulmonary hypertension is a fatal disease characterized by vasoconstriction and vascular remodeling. Loss of endothelial nitric oxide bioavailability is implicated in pulmonary hypertension pathogenesis. Recent evidence suggests that the cofactor tetrahydrobiopterin (BH4) is an importan...
Principais autores: | Khoo, J, Zhao, L, Alp, N, Bendall, J, Nicoli, T, Rockett, K, Wilkins, MR, Channon, K |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2005
|
Registros relacionados
-
Tetrahydrobiopterin deficiency uncouples nitric oxide synthase and causes pulmonary hypertension
por: Khoo, J, et al.
Publicado em: (2004) -
Prevention of hypoxia-induced pulmonary hypertension and vascular remodelling by targeting endothelial tetrahydrobiopterin-dependent nitric oxide synthase regulation
por: Khoo, J, et al.
Publicado em: (2005) -
Tetrahydrobiopterin deficiency causes pulmonary hypertension: Effects on lung superoxide levels, hypoxic pulmonary vasoconstriction and vascular remodelling
por: Khoo, J, et al.
Publicado em: (2004) -
Endothelial tetrahydrobiopterin regulates eNOS coupling/uncoupling independent of vascular disease: Insights from targeted transgenic models
por: Bendall, J, et al.
Publicado em: (2004) -
Endothelial tetrahydrobiopterin (BH4) regulates eNOS coupling in vivo: Functional effects of BH4-eNOS stoichiometry in endothelial targeted transgenic mice
por: Bendall, J, et al.
Publicado em: (2005)